01 September 2003
A case of severe rhabdomyolysis and myopathy caused by statin use alone
Jain Hitender, Mannam Sunitha, Singh ShailenderCase Rep Clin Pract Rev 2003; 4(2):63-65 :: ID: 429030
Abstract
Background: Drug-induced myopathy and rhabdomyolysis are rare adverse drug reactions. They have been reported more often after the introduction of the HMG-CoA reductase inhibitors. Myopathy caused by HMG-CoA reductase inhibitors (statins) alone is rare, but occurs more frequently when a statin is used with medications known to cause myopathy. It usually manifest after a few days of initiation of therapy, or after prolonged use. We report a case of myopathy related to statin monotherapy, developing shortly after being switched from atorvastatin to simvastatin. Case Report: A 47-year-old female presented with two weeks history of progressive proximal weakness of all four extremities. Her symptoms started few days after being switched from atrovastatin to simvastatin by her physician, which she was using for the last two years. Physical examination confirmed shoulder and pelvic girdle muscle weakness. Laboratory data revealed a serum creatinine kinase (CK) of 35.250 U/L. Electromyographic study was consistent with the diagnosis of myopathy. The diagnosis of statin related myopathy with rhabdomyolysis was entertained and simvastatin was discontinued. The patient received supportive treatment and improved subsequently. Conclusions: The safety and tolerability of the available statins support their use as the first-line treatment of patients at high risk for coronary heart disease, since the clinical benefits greatly outweigh the small risk of myopathy. Nevertheless, clinicians should be aware of the adverse effects related to statin therapy, even after prolonged therapy. Patients should be advised to watch for generalized muscle pain or weakness, and if it occurs, should report to the physician immediately.
Keywords: statins, rhabdomylosis, myopath
22
In Press
06 Mar 2024 : Case report
Successful Healing of Periapical Pathology with Partial Pulpotomy in a Mature Permanent Molar: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942937
12 Mar 2024 : Case report
Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeu...Am J Case Rep In Press; DOI: 10.12659/AJCR.943244
13 Mar 2024 : Case report
Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diag...Am J Case Rep In Press; DOI: 10.12659/AJCR.943275
13 Mar 2024 : Case report
Unveiling the Temporal Aspect of MRI Tattoo Reactions: A Prospective Evaluation of a Newly-Acquired Tattoo ...Am J Case Rep In Press; DOI: 10.12659/AJCR.943411
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250